REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Clinicus Klaipeda (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Ambulatory Health Care Services
Secondary Activities: Offices of Physicians
Full name: UAB Clinicus Klaipeda Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

UAB Clinicus Klaipeda is a company in Lithuania, with a head office in Klaipeda. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on July 10, 2013. 80 (2025) employees currently work for UAB Clinicus Klaipeda. The latest financial highlights indicate a net sales revenue increase of 18.05% in 2023. UAB Clinicus Klaipeda’s net profit margin decreased by 8.53% in 2023.

Headquarters
Sendvario sen. Aukstkiemiu k. Ringelio al. 15
Klaipeda; Klaipeda County; Postal Code: LT-92359

Contact Details: Purchase the UAB Clinicus Klaipeda report to view the information.

Basic Information
Total Employees:
Purchase the UAB Clinicus Klaipeda report to view the information.
Registered Capital:
Purchase the UAB Clinicus Klaipeda report to view the information.
Financial Auditors:
Purchase the UAB Clinicus Klaipeda report to view the information.
Incorporation Date:
July 10, 2013
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Clinicus Klaipeda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
18.05%
Total operating revenue
18.05%
Net Profit (Loss) for the Period
-22.72%
Total equity
20.12%
Net Profit Margin
-8.53%
Return on Equity (ROE)
-10.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?